SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-21-000094
Filing Date
2021-10-12
Accepted
2021-10-12 09:19:20
Documents
14
Period of Report
2021-10-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20211011.htm   iXBRL 8-K 42522
2 EX-99.1 goss-20211011xexx991.htm EX-99.1 18524
6 GRAPHIC gossamerbio-logoxrega.jpg GRAPHIC 150783
  Complete submission text file 0001728117-21-000094.txt   413216

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20211011.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20211011_lab.xml EX-101.LAB 24975
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20211011_pre.xml EX-101.PRE 13193
7 EXTRACTED XBRL INSTANCE DOCUMENT goss-20211011_htm.xml XML 10827
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 211317222
SIC: 2834 Pharmaceutical Preparations